Oncolys Biopharma Inc
TSE:4588
Oncolys Biopharma Inc
Change in Working Capital
Oncolys Biopharma Inc
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
O
|
Oncolys Biopharma Inc
TSE:4588
|
Change in Working Capital
¥574.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
GNI Group Ltd
TSE:2160
|
Change in Working Capital
-¥2.8B
|
CAGR 3-Years
-183%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
PeptiDream Inc
TSE:4587
|
Change in Working Capital
¥5.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Change in Working Capital
-¥6.4B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-21%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Change in Working Capital
-¥36.9m
|
CAGR 3-Years
18%
|
CAGR 5-Years
29%
|
CAGR 10-Years
17%
|
S
|
StemRIM Inc
TSE:4599
|
Change in Working Capital
¥377.2m
|
CAGR 3-Years
73%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
See Also
What is Oncolys Biopharma Inc's Change in Working Capital?
Change in Working Capital
574.2m
JPY
Based on the financial report for Dec 31, 2023, Oncolys Biopharma Inc's Change in Working Capital amounts to 574.2m JPY.
What is Oncolys Biopharma Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
61%